Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MRTX-1133 + ONC212 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MRTX-1133 | MRTX1133|MRTX 1133 | KRAS G12D Inhibitor 16 | MRTX-1133 selectively inhibits KRAS G12D, which results in decreased downstream signaling and potentially leads to reduced tumor growth (PMID: 34889605). | |
ONC212 | ONC 212|ONC-212 | ONC212 is a trifluoromethylbenzyl imipridone that activates cellular stress response pathways, inhibits tumor metabolic pathways, and decreases FOXO3, AKT, ERK and mTOR signaling and levels of Myc, potentially leading to increased tumor cell apoptosis, cell cycle arrest, and tumor growth inhibition (PMID: 30037819, PMID: 28489985). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|